logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Allergan, Inc. drugs

    FiltersReset Filters
    55 results

    • actonel - risedronate sodium tablet, film coated

      (Risedronate Sodium)
      Allergan, Inc.

    • acular

      (Ketorolac Tromethamine)
      Allergan, Inc.
      Usage: ACULAR® ophthalmic solution is indicated for temporary relief of ocular itching from seasonal allergic conjunctivitis and for treating postoperative inflammation following cataract extraction.

    • acular ls - ketorolac tromethamine solution/ drops

      (Ketorolac Tromethamine)
      Allergan, Inc.

    • acuvail - ketorolac tromethamine solution/ drops

      (Ketorolac Tromethamine)
      Allergan, Inc.

    • aczone

      (dapsone)
      Allergan, Inc.
      Usage: ACZONE® Gel, 5%, is indicated for the topical treatment of acne vulgaris.

    • alocril - nedocromil sodium solution/ drops

      (Nedocromil Sodium)
      Allergan, Inc.

    • alphagan p

      (brimonidine tartrate)
      Allergan, Inc.
      Usage: ALPHAGAN P (brimonidine tartrate ophthalmic solution) is indicated for reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

    • atelvia

      (risedronate sodium)
      Allergan, Inc.
      Usage: Atelvia is indicated for treating osteoporosis in postmenopausal women, reducing vertebral and nonvertebral osteoporosis-related fractures. The optimal duration of use is undetermined, with recommendations for periodic re-evaluation of therapy need, especially for patients at low fracture risk after 3 to 5 years.

    • avycaz

      (ceftazidime, avibactam)
      Allergan, Inc.
      Usage: AVYCAZ (ceftazidime and avibactam) is indicated for treating complicated intra-abdominal and urinary tract infections, including pyelonephritis, as well as hospital-acquired and ventilator-associated bacterial pneumonia. It targets susceptible gram-negative bacteria in adult and pediatric patients (≥31 weeks gestational age).

    • botox

      (onabotulinumtoxinA)
      Allergan, Inc.
      Usage: BOTOX is indicated for treating overactive bladder, detrusor overactivity in adults and pediatric patients, chronic migraines, spasticity, cervical dystonia, severe primary axillary hyperhidrosis, and blepharospasm/strabismus. It is prescribed for patients unresponsive to or intolerant of anticholinergic medications. Limitations in efficacy for specific conditions are noted.